Contents
The Ministry of Health informed that there were 3454 coronavirus infections in our country last day. Last Friday, there were 3852 infections. 19 people died from COVID-11, 29 less than a week ago.
- Last day, 3454 cases of coronavirus infections were detected in Poland, while 3852 cases were reported a week ago
- 19 people have died from COVID-11
- 12 tests were performed for the presence of the virus
- 24 doses of vaccine were administered in the last 18 hours
- You can find more such stories on the TvoiLokony home page
According to the information of the Ministry of Health on September 2, last day there was 3454 coronavirus infections. A week ago, there were 3852 cases.
19 people have died from COVID-11. Last Friday, the death toll was 40.
Nobody recovered. 12 tests for the presence of SARS-CoV-090 were performed on the last day.
What is the course of the pandemic in Poland? You will see in the chart below:
Which provinces have the most infections?
The largest number of infections during the past day was detected in the province. Mazowieckie – 278.
The situation in the provinces with the highest daily number of infections is presented in the following charts:
You can check the number of infections in all provinces HERE.
Niedzielski: Omikron vaccines soon available in Poland
On September 1, the Committee for Medicines for Human Use (CHMP) of the European Medicines Agency (EMA) recommended the approval of two vaccines targeting the Omikron BA.1 sub-option in addition to the original SARS-CoV-2 strain. These are bivalent preparations by BioNTech / Pfizer and Moderna.
You are not sure if your ailments indicate COVID-19? Reach for a convenient antigen test that you can do yourself at home. You will find it in Medonet Market.
Health Minister Adam Niedzielski announced that vaccines will soon be available in Poland.
«Studies have shown that Comirnaty Original / Omicron BA.1 and Spikevax Bivalent Original / Omicron BA.1 can elicit a strong immune response against Omikron BA.1 and the original SARS-CoV-2 strain in previously vaccinated individuals. In particular, they were more effective in eliciting immune responses against the BA.1 sub-variant than the original vaccines. The side effects seen with the adapted vaccines were comparable to those seen with the original vaccines and were usually mild and of a short duration. Both CHMP opinions will now be sent to the European Commission, which will take a final decision, »the EMA informed.
The decision of the Committee for Medicinal Products for Human Use was also announced by the Minister of Health, Adam Niedzielski. As he announced, the preparations will soon be available in Poland.
“Today the EMA decided to vaccinate people from the age of 12 with a second booster dose of preparations targeting the omicron mutation. @EU_Commission will approve the decision today or tomorrow. Vaccines soon in PL »- wrote Niedzielski on Twitter.
A bivalent (bivalent) vaccine is more versatile than a preparation directed against only one variant. It was developed on the basis of the original SARS-CoV-2 virus and the Omikron variant. This allows it to fight two different strains of the virus and possibly provide immunity in the event of new, yet unknown variants of the coronavirus emerging.